Skip to main content

Intelligent Bio Solutions Adds Quantum TM to 400+ Account Portfolio Utilizing Breakthrough Fingerprint Drug Testing

Quantum Traffic Management transitions from saliva and urine testing to non-invasive, in-house fingerprint sweat-based drug screening Most recent client added to INBS’s portfolio of more than 400 accounts across the globe, as the Company plans entry into the US market in 2025 NEW YORK, Jan. 29, 2025 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that Quantum Traffic Management (“Quantum TM”), a leading UK-based traffic management provider, has adopted INBS’ Intelligent Fingerprinting Drug Testing Solution across its 10 nationwide sites to increase workplace testing efficiency and safety. With over 30 years of industry experience, Quantum TM operates across the utilities, highways,...

Continue reading

IPG Photonics to Showcase Innovative Fiber Laser Solutions for Micro-Machining, Cleaning, Scientific, and Advanced Applications at Photonics West 2025

MARLBOROUGH, Mass., Jan. 29, 2025 (GLOBE NEWSWIRE) — IPG Photonics Corporation (NASDAQ: IPGP), the global leader in fiber laser technology, will showcase new and innovative fiber laser solutions at Photonics West, January 28-30, 2025 in San Francisco. The 1,200 square foot booth will display a wide range of laser sources and laser technologies designed to optimize performance in applications including cleaning, cutting, marking, micro-machining, and quantum computing.  Next-Generation High-Power Laser Platform Improves Performance and Power-to-Volume Ratio IPG will present their new YLS-RI fiber laser platform built with an improved internal architecture to maximize performance and ease of integration. Developed as part of the company’s ongoing commitment to innovation, this new high-power laser platform features next-generation...

Continue reading

ibex Earns Fifth Great Place to Work® Certification™ in Nicaragua, Recognizing World-Class Workplace Culture and Employee Experience

ibex Earns Fifth Great Place to Work® Certification™ in Nicaraguaibex is proud to be recognized for its outstanding culture and inclusive workplaceMANAGUA, Nicaragua, Jan. 29, 2025 (GLOBE NEWSWIRE) — ibex (NASDAQ: IBEX), a leading global provider of business process outsourcing (BPO) and AI-powered customer engagement technology solutions, is proud to be Certified™ by Great Place to Work® in Nicaragua for the fifth time overall. This prestigious certification recognizes employers who create an outstanding employee experience and is based entirely on what current employees say about their experience working at ibex. The past year has been transformative for ibex Nicaragua, with the business experiencing strong growth. ibex Nicaragua has expanded to more than 2,100 seats and is poised to surpass 2,200 employees....

Continue reading

Reporting of granting of Tryg shares by senior management

Group CEO Johan Kirstein Brammer has been granted 38,867 Tryg shares for a total amount of DKK 5,686.242.10. Granting of the shares are related to the bonus programme in 2020 and the acquisition of RSA Scandinavia in 2021. Group COO Lars Bonde has been granted 37,813 Tryg shares for a total amount of DKK 5,532,041.90. Granting of the shares are related to the bonus programme in 2020 and the acquisition of RSA Scandinavia in 2021.Attachment08_2025.29.01 Transaction statement

Continue reading

Janover Advances SaaS Platform with AI-Powered Natural Language Search

Janover’s customers are delighted as it accelerates customers in its fastest-growing SaaS product to sift through millions of data points to find the data, fast, using AI. BOCA RATON, FL, Jan. 29, 2025 (GLOBE NEWSWIRE) — Janover Inc. (Nasdaq: JNVR) (“Janover” or the “Company”), an AI-enabled platform connecting the multifamily and commercial real estate industry, today announced the launch of advanced artificial intelligence search capabilities within Janover Pro, its leading multifamily and commercial property financing B2B SaaS marketplace. The new AI-powered search functionality enables multifamily and commercial real estate professionals to efficiently identify suitable lenders by simply describing their loan scenarios in natural language with the AI triaging millions of data points in seconds...

Continue reading

Genius Metals Changes Its Name to “Morocco Strategic Minerals Corporation”

MONTRÉAL, Jan. 29, 2025 (GLOBE NEWSWIRE) — Genius Metals Inc. (TSXV: GENI) (the “Company”) held its annual and special meeting of shareholders on January 16th, 2025 (the “Meeting”). The Company is pleased to announce that shareholders representing more than 99% of votes cast approved a special resolution authorizing the Company to amend its articles to change its name to “Morocco Strategic Minerals Corporation” and “Corporation de minéraux stratégiques du Maroc” as its French name. The common shares of the Company continue to trade on the TSX Venture Exchange (“TSXV”) under its existing trading symbol, GENI. The effective date of the name change will be January 31st, 2025 and the Company’s common shares will commence trading on the TSXV under the new name and under the trading...

Continue reading

Anfield Announces Completion of Verification Drilling, Plans for Updated Resource and Mine Permitting at Slick Rock

VANCOUVER, British Columbia, Jan. 29, 2025 (GLOBE NEWSWIRE) — Anfield Energy Inc. (TSX.V: AEC; OTCQB: ANLDF; FRANKFURT: 0AD) (“Anfield” or the “Company”) is pleased to announce that it has completed a 14-hole, 14,100-foot rotary drill program at its Slick Rock uranium and vanadium project, located in San Miguel County, Colorado. Anfield will use the drill results to both upgrade its uranium and vanadium resource estimate for Slick Rock – as found in its existing PEA – and prepare mine designs for a large mine permit for the project. Corey Dias, Anfield’s CEO, commented: “We are very pleased to have completed our Slick Rock drill program as part of our plan to advance our Slick Rock project through the permitting stage and, ultimately, to production. Anfield will pursue a Plan of Operations and mine plan for Slick Rock in 2025....

Continue reading

Telos Corporation Selected as Prime Contractor for the U.S. Navy SeaPort Next Generation Contract

ASHBURN, Va., Jan. 29, 2025 (GLOBE NEWSWIRE) — Telos Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, today announced its on-ramp as a prime contractor to the U.S. Navy – SeaPort Next Generation (SeaPort NxG) multiple award, indefinite-delivery/indefinite-quantity (IDIQ) contract. SeaPort NxG serves the Navy Virtual SYSCOM Commanders, including NAVAIR, NAVFAC, NAVSEA, NAVSUP, NAVWAR and ONR, as well as the Military Sealift Command (MSC) and the United States Marine Corps (USMC). SeaPort NxG is the U.S. Navy’s integrated and mandatory approach to contracting for professional support services (PSS). As a prime contractor, Telos will be eligible to bid on task orders until 2028, at which time the Navy will perform a re-compete for...

Continue reading

HealthTab™ and Patients Know Best® Bring Pharmacy-Based Blood Test Results to Millions in UK

VANCOUVER, British Columbia, Jan. 29, 2025 (GLOBE NEWSWIRE) — Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) today announced its successful integration of HealthTab™ the Company’s cloud-connected, pharmacy-based platform for testing and health data management, with Patients Know Best (PKB), the UK’s leading patient personal health record (PHR). The new partnership enables a seamless connection between real-time diagnostic results from pharmacy point-of-care testing and PKB’s PHR platform, enhancing data accessibility for patients and healthcare providers alike. Supporting HealthTab’s pilot with North East London, an existing PKB customer, this collaboration marks a significant step forward in advancing the government’s shift to community based screening and a more preventative approach...

Continue reading

Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on February 5

SAN DIEGO, Jan. 29, 2025 (GLOBE NEWSWIRE) — Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, is pleased to invite investors to a webinar on February 5, 2025, at 4:15 p.m. ET. The exclusive event, hosted by RedChip Companies, will feature Calidi CFO Andrew Jackson and CSO Antonio F. Santidrian, PharmD. PhD, who will share insight into the company’s groundbreaking cell-based delivery platforms designed to protect, amplify, and potentiate oncolytic viruses for enhanced cancer treatment. Highlights will include overviews of Calidi’s lead programs, such as its CLD-400 systemic platform targeting metastatic cancers, CLD-201 for advanced solid tumors and CLD-101 for high-grade glioma. A live Q&A session with the leadership...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.